Clinical trial · Observational
Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease
How Burdensome is the Diagnostic Phase ? Distress and Quality of Life in Patients Suspected of Having a (Serious) Lung Disease
NCT02060877CI-TRIAL-00024476DIADISScompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to gain insight in the distress experience and quality of life of patients suspected of having a serious lung disease during the diagnostic phase and the period between diagnosis and start of treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Suspected Lung Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| observational study: use of patient questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients suspected of having lung cancer
- description
- observational study, there is no study intervention, only patient questionnaires
- interventionNames
- Other: observational study: use of patient questionnaires
Primary outcomes (4)
- measure
- longitudinal assessment of distress
- timeFrame
- at time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment start
- description
- patient reported questionnaire (distress barometer)
- measure
- longitudinal assessment of quality of life
- timeFrame
- at time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment start
- description
- patient reported questionnaire (EORTC QLQ-C30 + lung cancer module)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * ambulatory patient * imaging suggestive of lung cancer * written informed consent * able to complete questionnaires Exclusion Criteria: * solitary pulmonary nodule * previous diagnosis of cancer
References
Publications (0)
Data not yet available
No reference posted for this study.